Transaction · 0001193125-26-001611

Bristol James Arthur

Bristol James Arthur, DIR, reported a transaction classified as grant at Erasca, Inc. involving 37762.000000 shares for an estimated $0.00. Reported holdings after the transaction were 37762.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ADIR
ERASErasca, Inc.
Filing timeJan 05
Trade dateJan 01, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$3.59
Pre-filing
1mo ago -16.4%1w ago -16.4%1d ago -16.4%
Returns since
7d +0.0%30d +195.5%90d +362.4%180d +414.5%1y +405.3%

ERAS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ERAS since 2026-01-05Filed 241 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001193125-26-001611
Stock Option (right to buy)
Transaction date
Jan 01, 2026
Filed Jan 05, 2026, 02:00 PM · 4d delay
Shares
37.7k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
37.7k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2026 in connection with each position on the issuer's board of directors and…

  2. F2

    The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of direc…

Original filing · 0001193125-26-001611
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ERAS